Minas P Economides (Minas Economides, M P Economides)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 6

Top Topics

Prostate Cancer

Tyrosine Kinase

Hepatitis C Virus

Top Venues

Expert review of clinical pharmacology

Cancer medicine

Therapeutic advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew L Laccetti, Benjamin Garmezy, Lianchun Xiao, Minas P Economides, Aradhana Venkatesan, Jianjun Gao, Eric Jonasch, Paul Corn, Amado Zurita-Saavedra, Landon C Brown, Chester Kao, Emily N Kinsey, Rajan T Gupta, Michael R Harrison, Andrew J Armstrong, Daniel J George, Nizar Tannir, Pavlos Msaouel, Amishi Shah, Tian Zhang, Matthew T Campbell
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes. Cancer medicine 10 (7) (2021)
Minas P Economides, Deborah McCue, Andrew A Lane, Naveen Pemmaraju
Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm. Expert review of clinical pharmacology 12 (10) (2019)
Minas P Economides, Marina Konopleva, Naveen Pemmaraju
Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm. Therapeutic advances in hematology 10 (2019)
Minas P Economides, T L Shigle, H A Torres
Letter: should direct-acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus-infected patients with cancer? Authors' reply. Alimentary pharmacology & therapeutics 45 (5) (2017)
Minas P Economides, Moran Amit, Parag S Mahale, Jeff J Hosry, Ying Jiang, Uddalak Bharadwaj, Erich M Sturgis, Harrys A Torres
Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer. Cancer 124 (5) (2017)
Jeff J Hosry, Roberto N Miranda, Felipe Samaniego, Minas P Economides, Harrys A Torres
Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients. International journal of cancer 142 (5) (2017)